SOCIAL ENTERPRISES ADVANCE
THE VALUE OF CORD BLOOD
CCBC formed an enterprise subsidiary, the Cleveland Cell Therapy Incubator (CCTI). This entity expands our operations from collection and research to initial proof of concept to intellectual property and eventually to new products introduced into the marketplace that provide cellular therapy treatments.
This organizational strategic outlook drives our focus on creating a cohesive, innovative, research-driven organization recognized for cellular therapy advancement, patient care, leadership, technology and collaboration.
ABOUT THE CLEVELAND CELL THERAPY INCUBATOR (CCTI)
The state-of-the-art Cleveland Cell Therapy Incubator (CCTI) hosts high-specialty programs for the advancement of new cell processing technologies and products. The facility, designed and monitored for Good Manufacturing Practice (GMP)-compliance, helps move innovative cellular therapy and cord blood products from Research & Development along the path to FDA approval.